期刊文献+

和肽素的研究进展——一种新的心血管疾病的标记物 被引量:12

Copeptin as a New Marker of Cardiovascular Disease
下载PDF
导出
摘要 和肽素(copeptin)是精氨酸加压素原C末端的一部分,近年来研究发现其在心血管疾病的诊断及预后判断等方面有重要价值,特别是在冠心病急性心肌缺血梗死的诊断和晚期心力衰竭的预后判断方面,现就copeptin的一些生理特性及其在心血管疾病中的研究作一综述。 Copeptin(and peptide) is the C terminus of arginine vasopressin.Recent research suggests that the diagnosis and prognosis of cardiovascular disease,especially in acute myocardial ischemia and infarction,should take copeptin account.This article reviews recent studies of copeptin as a marker for cardiovascular disease.
出处 《心血管病学进展》 CAS 2011年第2期175-178,共4页 Advances in Cardiovascular Diseases
关键词 和肽素 心血管疾病 急性心肌缺血 心力衰竭 copeptin cardiovascular disease acute myocardial ischemia heart failure
  • 相关文献

参考文献21

  • 1Hupf H, Grimm D, Schunkert H, et al. Evidence for a vasopressin system in the rat heart[J]. Circ Res, 1999, 84(3) : 365-370.
  • 2李春盛,田茹敏,高秀兰,李爱民,齐平.急性心肌梗塞患者血浆内阿片肽和精氨酸加压素含量及其临床意义[J].中国危重病急救医学,1996,8(5):287-289. 被引量:9
  • 3Valli G, Fedeli A, Palange P, et al. Water and sodium imbalance in COPD patients[J]. Monaldi Arch Chest Dis, 2004, 61(2) : 112-116.
  • 4Friedmann AS, Mallot KA, North WG, et al. Products of vasopressin gene ex- pression in small-cell carcinoma of the lung[J]. Br J Cancer, 1994, 69: 260- 263.
  • 5Morgenthaler NG, Struck J, Bergmann A, et al. Assay for the measurement of copeptin - a stable peptide derived from the precursor of vasopressin [ J ]. Clin Chem, 2006, 52(1): 112-119.
  • 6Barat C, Simpson L, Breslow E, et al. Properties of human vasopressin precursor constructs : inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus [J]. Biochemistry, 2004, 43(25) : 8191- 8203.
  • 7Jochberger S, Morgenthaler NG, Mayr VD, et al. Copeptin and arginine vasopressin concentrations in critically ill patients [ J ]. J Clin Endocrinol Metab, 2006, 91 ( 1 l ) : 4381-4386.
  • 8Katan M, Morgenthaler NG, Dixit KC, et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin as- say [J]. J Clin Endoefinol Metab, 2007, 92(7) : 2640-2643,.
  • 9肖洋,张志刚,柴三葆,褚松云,戚豫,唐朝枢.多种疾病患者血浆copeptin测定[J].放射免疫学杂志,2008,21(2):97-100. 被引量:18
  • 10Khan SQ, 1)hillon OS, Quinn PA, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptidc (LAMP) study [ J ]. Circulation, 2007, 115(16) : 2103-2110.

二级参考文献21

  • 1许铁.内源性阿片物质在内毒素和心源性休克中的作用机制研究[J].生理科学进展,1993,24(3):248-251. 被引量:14
  • 2孟建中,宋萍,王成海,黄爱军.β-内啡肽在血液透析病人无症状心肌缺血中的作用[J].解放军医学杂志,1994,19(5):348-350. 被引量:1
  • 3李春盛,田茹敏,高秀兰,李爱民,齐平.急性心肌梗塞患者血浆内阿片肽和精氨酸加压素含量及其临床意义[J].中国危重病急救医学,1996,8(5):287-289. 被引量:9
  • 4Hupf H, Grimm D, Schunkert H, et al. Evidence for a vasopressin system in the rat heart. Circ Res. 1999,29:35.
  • 5Valli G, Fedeli A, Palange P, et al. Water and sodium imbalance in COPD patients. Monaldi Arch Chest Dis. 2004,61 (2) :112.
  • 6Friedmann AS. , Mallot KA. , North WG. , et al. Products of vasopressin gene expression in small - cell carcinoma of the lung. Br J Cancer. 1994,69:260.
  • 7Morgenthaler NG, Struck J, Bergmann A, et al. Assay for the measurement of copeptin, a stable peptlde derived from the precursor of vasopressin. Clin Chem. 2006,52(1) :112.
  • 8Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides. 2005,26(12) :2500.
  • 9Jochberger S, Morgenthaler NG, Du nser MW, et al. Copaptin and arglnine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab. 2006,91(11) :4381.
  • 10Jochbergcr S, Luckner G, Morgenthaler NG, et al. Course of vasopressin and copeptin plasma concentrations in a patient with pevere septic shock. Anaesth Intensive Care. 2006,34 (4) :498.

共引文献24

同被引文献125

  • 1李春盛,田茹敏,高秀兰,李爱民,齐平.急性心肌梗塞患者血浆内阿片肽和精氨酸加压素含量及其临床意义[J].中国危重病急救医学,1996,8(5):287-289. 被引量:9
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15750
  • 3Kehi DW, Iqbal N, Fard A, et al. Biomarkers in acute myocardial injury [J]. Transl Res, 2012, 159 (4): 252-264.
  • 4Michalaki M, Margeli T, Tsekouras A, et al. Hypotlialamic -pituitary - adrenal axis response to the severity of illness in non - critically ill patients: does relative corticosteroid insufficiency exist? [ J]. European Journal of Endocrinology, 2010, 162 (10) : 341 -347.
  • 5Katan M, Christ - Crain M. The Stzess hormone eepeptin : a new propnostie biomarker in acute illness [ J]. Swiss Medical Weekly, 2010, 140: 13101.
  • 6Steg PC., James SK, Atar D, et al.ESU Gmuennes for the management of acute myocardial infarction in pa- tients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J, 2012, 33 (20): 2569-2619.
  • 7Coviello I, Pinnacchio G, Laurito M, et al. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology, 2013, 124 (1): 63-70.
  • 8Kosuge M, Kimura K. Clinical implications of electrocardiograms for patients with anterior wall ST-segment elevation acute myocardial infarction in the interventional era. Circ J, 2012, 76 (1): 32-40.
  • 9Jochberger S, Morgenthaler NG, Mayr VD, et al. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab, 2006, 91 (11): 4381-4386.
  • 10Mastropietro CW, Mahan M, Valentine KM, et al. C- opeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery. Intensive Care Med, 2012, 38 (12): 2047-2054.

引证文献12

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部